دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
The essential role of dermatology publications in enhancing professional diversity, equity and inclusion
S. Burgin,N.C. Dlova,J.R. Ingram,L.C. Parish,L.A. Goldsmith,
doi : 10.1111/bjd.20473
Volume 185, Issue 3 p. 473-474
Interventions for basal cell carcinoma: from evidence to personalized treatment
L.C.J. van Delft,N.W.J. Kelleners-Smeets,
doi : 10.1111/bjd.20059
Volume 185, Issue 3 p. 475-475
In the past 14 years since the publication of the last Cochrane review on interventions for basal cell carcinoma (BCC), the incidence of BCC has continued to rise rapidly, putting a large burden on healthcare systems.1, 2 Thomson et al. describe an extensive update of the Cochrane review on interventions for BCC in this issue of the BJD.3
The need for comparative effectiveness data to guide management of acne vulgaris
J.S. Barbieri,A.M. Drucker,
doi : 10.1111/bjd.20499
Volume 185, Issue 3 p. 476-477
How clinical phenotypes can translate into taxonomy: can we judge atopic dermatitis by its cover?
C. Vestergaard
doi : 10.1111/bjd.20434
Volume 185, Issue 3 p. 477-477
Icelandic study of cutaneous squamous cell carcinoma (cSCC) epidemiology highlights the worldwide burden of disease and challenges of in situ and invasive cSCC registry data
Z.C. Venables
doi : 10.1111/bjd.20422
Volume 185, Issue 3 p. 477-478
In the UK, from 2013 to 2015, cutaneous squamous cell carcinomas (cSCCs) affected 111 per 100 000 person years (PY) in men and 42 per 100 000 PY in women, with the incidence rising by around 5% every year.1 Adalsteinsson et al., in this issue, report a substantially lower incidence of 14 and 13·2 per 100 000 PY in men and women, respectively, in Iceland in 2017.2 This difference may, in part, be owing to the fact that the Icelandic registry reports only the first tumour, which under-reports by up to 50%, compared with the UK data, where the first tumour per patient per annum is reported.1 There is also geographical variation with lower ultraviolet radiation (UVR) exposure at the higher Icelandic latitudes.
Development of tools for the evaluation of pruritus
L. Misery
doi : 10.1111/bjd.20492
Volume 185, Issue 3 p. 478-479
Regional differences between Japan and the Netherlands in atopic dermatitis patient-reported outcome measures: which interpretation?
A. Taïeb,N. Katoh,
doi : 10.1111/bjd.20424
Volume 185, Issue 3 p. 479-480
Immunological and clinical heterogeneity in cutaneous lupus erythematosus
T. Vazquez,R. Feng,K. J. Williams,V. P. Werth,
doi : 10.1111/bjd.20085
Volume 185, Issue 3 p. 480-481
Food for thought: does host diet affect skin microbes?
A.M. Schneider,A.M. Nelson,
doi : 10.1111/bjd.20573
Volume 185, Issue 3 p. 481-483
Search for the best biologic for psoriasis
M. Sugaya
doi : 10.1111/bjd.20514
Volume 185, Issue 3 p. 483-483
Mechanism of action of dimethyl fumarate: a small molecule with big effects
B. Kirby,J.M. Fletcher,
doi : 10.1111/bjd.20572
Volume 185, Issue 3 p. 483-484
Current agreement on the management of Stevens–Johnson syndrome and toxic epidermal necrolysis
C.-B. Chen,W.-H. Chung,
doi : 10.1111/bjd.20515
Volume 185, Issue 3 p. 484-486
Dermatology: the ‘added value’ specialty
S. Walsh
doi : 10.1111/bjd.20598
Volume 185, Issue 3 p. 486-486
A clinical and biological review of keratoacanthoma*
A. Tisack,A. Fotouhi,C. Fidai,B.J. Friedman,D. Ozog,J. Veenstra,
doi : 10.1111/bjd.20389
Volume 185, Issue 3 p. 487-498
Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments
J. Thomson,S. Hogan,J. Leonardi-Bee,H. C. Williams,F .J. Bath-Hextall,
doi : 10.1111/bjd.19809
Volume 185, Issue 3 p. 499-511
Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis*
B. Stuart,E. Maund,C. Wilcox,K. Sridharan,G. Sivaramakrishnan,C. Regas,D. Newell,I. Soulsby,K.F. Tang,A.Y. Finlay,H.C. Bucher,P. Little,A.M. Layton,M. Santer,
doi : 10.1111/bjd.20080
Volume 185, Issue 3 p. 512-525
Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohort
A.R. Mulick,K.E. Mansfield,R.J. Silverwood,A. Budu-Aggrey,A. Roberts,A. Custovic,N. Pearce,A.D. Irvine,L. Smeeth,K. Abuabara,S.M. Langan,
doi : 10.1111/bjd.19885
Volume 185, Issue 3 p. 526-536
Invasive and in situ squamous cell carcinoma of the skin: a nationwide study in Iceland
J.A. Adalsteinsson,E. Olafsdottir,D. Ratner,R. Waldman,H. Feng,J. Ungar,J.I. Silverberg,A.K. Kristjansson,J.G. Jonasson,L. Tryggvadottir,
doi : 10.1111/bjd.19879
Volume 185, Issue 3 p. 537-547
Refinement and validation of the ItchyQoL using classical test theory and item response theory resulted in a reduction of the response categories from a 5-point to a 3-point scale
M. Gabes,C. Zeidler,S. St?nder,S. C. Chen,C. J. Apfelbacher,
doi : 10.1111/bjd.20082
Volume 185, Issue 3 p. 548-554
Dupilumab treatment in patients with atopic dermatitis: a comparative cohort study between the Netherlands and Japan shows a discrepancy in patient-reported outcome measures
L.E.M. de Wijs,R.F.T. Fujimoto,E.R. Andrinopoulou,T. Nijsten,D. Hijnen,Y. Kataoka,
doi : 10.1111/bjd.19897
Volume 185, Issue 3 p. 555-562
Modular gene analysis reveals distinct molecular signatures for subsets of patients with cutaneous lupus erythematosus*
J. L. Zhu,L. T. Tran,M. Smith,F. Zheng,L. Cai,J. A. James,J. M. Guthridge,B. F. Chong,
doi : 10.1111/bjd.19800
Volume 185, Issue 3 p. 563-572
Host traits, lifestyle and environment are associated with human skin bacteria
L. Moitinho-Silva,N. Boraczynski,H. Emmert,H. Baurecht,S. Szymczak,H. Schulz,D. Haller,J. Linseisen,C. Gieger,A. Peters,L. Tittmann,W. Lieb,C. Bang,A. Franke,E. Rodriguez,S. Weidinger
doi : 10.1111/bjd.20072
Volume 185, Issue 3 p. 573-584
Signalling of multiple interleukin (IL)-17 family cytokines via IL-17 receptor A drives psoriasis-related inflammatory pathways
M.A.X. Tollenaere,J. Hebsgaard,D.A. Ewald,P. Lovato,S. Garcet,X. Li,S.D. Pilger,M.L. Tiirikainen,M. Bertelsen,J.G. Krueger,H. Norsgaard,
doi : 10.1111/bjd.20090
Volume 185, Issue 3 p. 585-594
Ca2+ signalling is critical for autoantibody-induced blistering of human epidermis in pemphigus*
T. Schmitt,D.T. Egu,E. Walter,A.M. Sigmund,R. Eichkorn,A. Yazdi,E. Schmidt,M. S?rdy,R. Eming,M. Goebeler,J. Waschke,
doi : 10.1111/bjd.20091
Volume 185, Issue 3 p. 595-604
Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of patients with psoriasis that are linked with skin improvement*
P.J. Morrison,I. Suhrkamp,S. Gerdes,U. Mrowietz,
doi : 10.1111/bjd.19899
Volume 185, Issue 3 p. 605-615
Supportive care in the acute phase of Stevens–Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus
M.-C. Brüggen,S.T. Le,S. Walsh,A. Toussi,N. de Prost,A. Ranki,B. Didona,A. Colin,B. Horv?th,E. Brezinova,B. Milpied,C. Moss,C. Bodemer,D. Meyersburg,C. Salavastru,G.-S. Tiplica,E. Howard,E. Bequignon,J.N. Bouwes Bavinck,J. Newman,J. Gueudry,M. N?geli,K. Zaghbib,K. Pallesen,A. Bygum,P. Joly,P. Wolkenstein,S.-L. Chua,R. Le Floch,N.H. Shear,C.-Y. Chu,N. Hama,R. Abe,W.-H. Chung,T. Shiohara,M. Ardern-Jones,P. Romanelli,E.J. Phillips,R.S. Stern,J. Cotliar,R.G. Micheletti,A. Brassard,J.T. Schulz,R.P. Dodiuk-Gad,A.R. Dominguez,A.S. Paller,L. Seminario-Vidal,A. Mostaghimi,M.H. Noe,S. Worswick,D. Tartar,R. Sheridan,B.H. Kaffenberger,K. Shinkai,E. Maverakis,L.E. French,S. Ingen-Housz-Oro
doi : 10.1111/bjd.19893
Volume 185, Issue 3 p. 616-626
Effect of dermatological consultation on survival in patients with checkpoint inhibitor-associated cutaneous toxicity
L.L. Thompson,E.B. Li,N.A. Krasnow,M.S. Chang,J.T. Said,G.E. Molina,N.J. Polyakov,J. Yoon,E.C. Dee,K. Huang,A.E. Blum,J.R. Kuchroo,A.N. Hinton,K.L. Reynolds,S.T. Chen,
doi : 10.1111/bjd.20074
Volume 185, Issue 3 p. 627-635
Differential profiles of gamma secretase Notch signalling in hidradenitis suppurativa: the need for genotype–endotype–phenotype analysis
J.W. Frew
doi : 10.1111/bjd.19805
Volume 185, Issue 3 p. 636-637
Immunological eruptions of ageing: reframing chronic pruritic rashes in older adults
M.K. Abel,S. Jelousi,T. Berger,J.E. Murase,D.C. Butler,
doi : 10.1111/bjd.20414
Volume 185, Issue 3 p. 638-639
SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study
C. Nguyen,K. Yale,F. Casale,A. Ghigi,K. Zheng,J.I. Silverberg,N.A. Mesinkovska,
doi : 10.1111/bjd.20435
Volume 185, Issue 3 p. 640-641
Air pollution and risk of hospital outpatient visits for eczematous skin disorders in metropolitan cities of South Korea
S. Park,K.H. Ha,T.-G. Kim,H.C. Kim,C. Kim,S.H. Oh,
doi : 10.1111/bjd.20079
Volume 185, Issue 3 p. 641-644
Evidence from a humanized mouse model of androgenetic alopecia that platelet-rich plasma stimulates hair regrowth, hair shaft diameter and vellus-to-terminal hair reconversion in vivo
R. Laufer Britva,A. Keren,A. Ginzburg,Y. Ullmann,R. Paus,A. Gilhar,
doi : 10.1111/bjd.20084
Volume 185, Issue 3 p. 644-646
Antibody responses to single-dose SARS-CoV-2 vaccination in patients receiving immunomodulators for immune-mediated inflammatory disease
A. Al-Janabi,Z. Littlewood,C.E.M. Griffiths,H.J.A. Hunter,H. Chinoy,C. Moriarty,Z.Z.N. Yiu,R.B. Warren,
doi : 10.1111/bjd.20479
Volume 185, Issue 3 p. 646-648
The burden of immune-mediated skin disease in inpatients with HIV/AIDS
A. Ji-Xu,D.K. Lei,K.A. Nguyen,J.J. Yang,M.K. Erickson,K. Cheng,S. Worswick,N.J. Maloney,
doi : 10.1111/bjd.20401
Volume 185, Issue 3 p. 648-650
Familial chilblain lupus in a child with heterozygous mutation in SAMHD1 and normal interferon signature
D.W. Linggonegoro,H. Song,K.M. Jones,P.Y. Lee,B. Schmidt,R.A. Vleugels,J.T. Huang,
doi : 10.1111/bjd.20400
Volume 185, Issue 3 p. 650-652
Itch in skin of colour: a multicentre cross-sectional study
N. Sutaria,V. Parthasarathy,Y.S. Roh,J. Choi,Z.A. Bordeaux,P. Trinh,T.K. Le,Y.R. Semenov,S.G. Kwatra,
doi : 10.1111/bjd.20403
Volume 185, Issue 3 p. 652-654
Outcomes of COVID-19 in patients with skin cancer
R. Raiker,H. Pakhchanian,A. Hussain,M. Deng,
doi : 10.1111/bjd.20386
Volume 185, Issue 3 p. 654-655
Dysbiotic gut microbiota in patients with inflammatory rosacea: another clue towards the existence of a brain–gut–skin axis
O.M. Moreno-Arrones,D. Ortega-Quijano,V. Perez-Brocal,D. Fernandez-Nieto,N. Jimenez,E. de las Heras,A. Moya,B. Perez-Garcia,
doi : 10.1111/bjd.20411
Volume 185, Issue 3 p. 655-657
Anti-C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single-centre, cross-sectional study
D.J. Dijkstra,S.I.E. Liem,N.M. van Leeuwen,C.M. Fehres,J.K. de Vries-Bouwstra,L.A. Trouw,
doi : 10.1111/bjd.20412
Volume 185, Issue 3 p. 657-658
Guidelines for the management of chronic spontaneous urticaria: recommendations supported by the Centre of Evidence of the French Society of Dermatology
F. Hacard,B. Giraudeau,G. d’Acremont,M.-H. Jegou,A.-P. Jonville-Bera,S. Munck,B.-N. Pham,S. Mavoungou,H. Cornillier,B. Guillot,M. Beylot-Barry,O. Chosidow,A. Maruani,
doi : 10.1111/bjd.20415
Volume 185, Issue 3 p. 658-660
Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis
H. Iznardo,E. Vilarrasa,A. L?pez-Ferrer,L. Puig,
doi : 10.1111/bjd.20416
Volume 185, Issue 3 p. 660-662
Decline in the use of phototherapy in France from 2010 to 2019
F. Aubin,C. Chaignot,I. Gallais-Serezal, on behalf of the Société Française de Photodermatologie,
doi : 10.1111/bjd.20384
Volume 185, Issue 3 p. 662-663
Complete response in a patient with advanced melanoma following anti-PD-1 therapy is associated with a high frequency of melanoma-infiltrating CXCR3+ resident memory CD8+ T cells and multiple chemokine pathways
L. Dousset,C. Martins,C. Jacquemin,S. Amico,T. Schatton,K. Boniface,J. Seneschal,
doi : 10.1111/bjd.20405
Volume 185, Issue 3 p. 663-666
Rarity of cutaneous findings among asymptomatic to mildly symptomatic patients with COVID-19 admitted to a COVID care facility in Delhi, India: an observational study
A. Khurana,A. Mittal,R. Jain,A. Mishra,S.R. Mathachan,
doi : 10.1111/bjd.20488
Volume 185, Issue 3 p. 666-667
Sterile abscesses possibly stem from acantholytic folliculitis in comedonal Darier disease: a case report
T. Komatsu-Fujii,T. Murata,E. Adachi,Y. Kaku,T. Wada,N. Nakagawa,S. Kosugi,T. Uehara,K. Kosaki,T. Kataoka,G. Egawa,T. Dainichi,K. Kabashima,
doi : 10.1111/bjd.20418
Volume 185, Issue 3 p. 667-669
Association between menopausal hormone therapy and incidence of psoriasis: a secondary analysis from the Women’s Health Initiative randomized clinical trials
A.A. Chan,J. Noguti,C.T. Yang,S.R. Feldman,R.B. Wallace,A.H. Shadyab,J.E. Manson,A.K. Aragaki,R.T. Chlebowski,D.J. Lee,
doi : 10.1111/bjd.20410
Volume 185, Issue 3 p. 669-671
Drop in biological initiation for patients with psoriasis during the COVID-19 pandemic
L. Penso,R. Dray-Spira,A. Weill,M. Zureik,E. Sbidian,
doi : 10.1111/bjd.20406
Volume 185, Issue 3 p. 671-673
Reporting of randomized controlled trial abstracts in dermatology journals according to CONSORT guidelines
M.L. McPhie,A.C. Bridgman,S.H. Voineskos,A.W. Chan,A.M. Drucker,
doi : 10.1111/bjd.20433
Volume 185, Issue 3 p. 673-675
Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna
A. Lallas,E. Moscarella,H. Kittler,C. Longo,L. Thomas,I. Zalaudek,A. Kyrgidis,S.M. Manoli,N. di Meo,C. Papageorgiou,Z. Apalla,G. Argenziano,
doi : 10.1111/bjd.20407
Volume 185, Issue 3 p. 675-677
Topical tofacitinib for the treatment of alopecia areata affecting facial hair
K.L.S. Kerkemeyer,R.D. Sinclair,B. Bhoyrul,
doi : 10.1111/bjd.20419
Volume 185, Issue 3 p. 677-679
Diagnostic performance of high-throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma
C. Zimmermann,M. Boisson,C. Ram-Wolff,A. Sadoux,B. Louveau,M.-D. Vignon-Pennamen,J. Rivet,J.-M. Cayuela,G. Dobos,H. Moins-Teisserenc,M. Roelens,A. Gruber,C. Lebbé,M. Bagot,M. Battistella,S. Mourah,A. de Masson
doi : 10.1111/bjd.20432
Volume 185, Issue 3 p. 679-680
Hailey–Hailey disease treated with dupilumab: a case series
N. Alzahrani,J. Grossman-Kranseler,R. Swali,K. Fiumara,P. Zancanaro,S. Tyring,D. Rosmarin,
doi : 10.1111/bjd.20475
Volume 185, Issue 3 p. 680-682
Professor John I. Harper MB, BS, MD, FRCP, FRCPCH; 1950–2021
P.H. Hoeger,V.A. Kinsler,
doi : 10.1111/bjd.20426
Volume 185, Issue 3 p. 683-684
Infection with Mycobacterium immunogenum after an injection lipolysis procedure
Y. Kong,H. Chen,J. Xiong,Z. Hao,
doi : 10.1111/bjd.20392
Volume 185, Issue 3 p. e68-e68
An unusual dermoscopic appearance of scabies
C. Wolfe,E. Rudd,J. Ng,J. Weir,L.C. Fuller,
doi : 10.1111/bjd.20423
Volume 185, Issue 3 p. e69-e69
19th Congress - European Society for Dermatology and Psychiatry (ESDaP) & 2nd Brain Skin Colloquium Conference. 11th - 12th June 2021
doi : 10.1111/bjd.20518
Volume 185, Issue 3 p. e70-e108
Revolutionizing Atopic Dermatitis, 13 June 2021
doi : 10.1111/bjd.20648
Volume 185, Issue 3 p. e109-e146
Diverse molecular signatures observed in patients with cutaneous lupus erythematosus
doi : 10.1111/bjd.20612
Volume 185, Issue 3 p. e147-e147
Cutaneous lupus erythematosus (CLE) is an autoimmune connective tissue disease affecting the skin. It has been estimated there are approximately 4·0 patients with the condition per 100,000 people. It affects more women than men and more African Americans than other ethnicities. CLE is a clinically diverse disease and can be divided into several subtypes including subacute CLE, discoid lupus erythematosus and lupus erythematosus tumidus.
Topical treatments for mild-to-moderate acne
doi : 10.1111/bjd.20613
Volume 185, Issue 3 p. e148-e148
Acne is very common in teenagers but also affects many adults. The impact on quality of life and self-confidence can be great. Mild-to-moderate acne is treated with creams, gels or lotions (topical treatments). There is little evidence about how these treatments compare with one another. This makes it difficult for patients and doctors to know which treatments to use.
Calcium signalling is important in the development of the condition pemphigus
doi : 10.1111/bjd.20614
Volume 185, Issue 3 p. e149-e149
A group of conditions called pemphigus cause severe blistering of the skin and the mucous membranes (which line the mouth, nose, throat, eyes and genital area). This study from Germany reports on our research into disease mechanisms involving the flow of dissolved calcium into types of skin cells called keratinocytes. These mechanisms are involved in the development of this autoimmune skin disease.
A review of keratoacanthoma
doi : 10.1111/bjd.20615
Volume 185, Issue 3 p. e150-e150
In this study, our team from the USA reviewed what is known about a skin growth called keratoacanthoma. Keratoacanthoma is a somewhat controversial skin lesion because it has very similar clinical and microscopic features to a type of skin cancer called cutaneous squamous cell carcinoma (cSCC), which can potentially spread internally (metastasize) whereas keratoacanthoma behaves in a benign (non-worrisome) manner.
A possible mechanism of action of the drug dimethyl fumarate in psoriasis
doi : 10.1111/bjd.20616
Volume 185, Issue 3 p. e151-e151
A drug called dimethyl fumarate (DMF) is an effective treatment for psoriasis and multiple sclerosis. In psoriasis it typically improves skin inflammation within the first 3 months of treatment. We know DMF acts on cells of the immune system but we currently do not understand very much more about exactly how it works.
????????????????
doi : 10.1111/bjd.20617
Volume 185, Issue 3 p. e152-e152
??????? (CLE) ???????????????????????, ? 100,000 ???? 4·0 ????????????????, ????????????CLE ???????, ???????, ????????????????????????????
??????????
doi : 10.1111/bjd.20618
Volume 185, Issue 3 p. e153-e153
????????, ?????????????????????????????????????????? (????) ????????????????????????????????????
???????????????
doi : 10.1111/bjd.20619
Volume 185, Issue 3 p. e154-e154
???“???”?????????????????? (????????????????) ???????????????????????“????”???????????????????????????????
???????
doi : 10.1111/bjd.20620
Volume 185, Issue 3 p. e155-e155
?????, ??????????????????“?????”??????????????????????????, ????????????“???????”(cSCC) ??????????????????????????????? (??) , ?????????? (????) ?
????????????????????
doi : 10.1111/bjd.20621
Volume 185, Issue 3 p. e156-e156
??????????? (DMF) ???????????????????????????? 3 ???, ???????????????????, DMF ?????????, ???????????????????
